NICOLE PEARCE: Open Payments
NPI 1295191716 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,583 in 72 payments from 29 companies in 2025. Trend: 2023 $1,967 · 2024 $2,501 · 2025 $1,583
Food & beverage: $1,583
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 12 | $231 |
| Novartis Pharmaceuticals Corporation | 11 | $212 |
| AstraZeneca Pharmaceuticals LP | 4 | $124 |
| SOBI, INC | 4 | $98 |
| Regeneron Healthcare Solutions, Inc. | 3 | $81 |
| GlaxoSmithKline, LLC. | 4 | $80 |
| SpringWorks Therapeutics, Inc. | 3 | $66 |
| ABBVIE INC. | 3 | $64 |
| Merck Sharp & Dohme LLC | 3 | $61 |
| Genmab U.S., Inc. | 2 | $57 |
Products named: KISQALI, Vonjo, EPKINLY, LIBTAYO, IMFINZI, SCEMBLIX, PADCEV, IBRANCE.
Industry payments across AZ — which companies pay providers there.
